FDA Cleared New Bedside EEG Software Tools

The technology aims to help doctors interpret brain wave data faster to improve care decisions for patients.

Updated on Sept. 30, 2026 in Stroke

FDA Cleared New Bedside EEG Software Tools

Live Poll

Do you believe new AI-powered diagnostic tools improve the quality of care in local hospitals?

The FDA has granted clearance for new software designed to streamline EEG trending and analysis in clinical settings. The tools are intended to help medical professionals make faster decisions by simplifying complex brain activity data at the bedside.

Why it matters

By automating the interpretation of complex EEG trends, this technology is designed to reduce the time needed for clinical teams to identify critical brain states. Faster data processing could improve the speed and accuracy of neurological assessments in urgent care environments.

The FDA granted 510(k) clearance for three new analytical capabilities, including Alpha-Delta Ratio trending and Burst Suppression monitoring, across all age groups. These tools update an existing platform that previously received clearance for neonatal seizure and delirium monitoring.

The players

FDA

The federal agency responsible for protecting public health by ensuring the safety and efficacy of medical devices and pharmaceuticals.

Ceribell

A medical technology company based in Sunnyvale, California, focused on developing point-of-care EEG solutions for brain monitoring.

The details

The platform utilizes portable hardware combined with AI-powered algorithms to convert raw EEG signals into simplified visual trends. By processing metrics like relative alpha and amplitude-integrated EEG, the system allows clinicians to visualize brain activity without requiring constant specialized neurological interpretation.

September 30, 2026: The FDA granted 510(k) clearance for the new software.
First half of 2027: Ceribell plans to release the new features via an automatic update.

Health Landscape

This clearance marks an expansion of the Ceribell System, which previously focused on targeted applications like neonatal seizure detection. The move toward broader age-inclusive monitoring reflects a wider trend in critical care toward accessible, real-time neurological data.

If a family member is in a critical care setting requiring continuous brain monitoring, this technology may eventually provide your care team with faster insights. Questions regarding the use of specific monitoring equipment and how data impacts treatment plans are always worth discussing with your doctor.

The takeaway

The FDA-cleared software is designed to simplify complex brain wave data at the bedside to help medical teams make faster, better-informed care decisions. If you have questions about neurological monitoring protocols for a hospitalized patient, ask your care team about their EEG capabilities.